ʻO ka maʻi hepatitis pohihihi i nā keiki. ʻO ke kī i ka wehewehe ʻana ʻo COVID-19?

Ke hoʻomau nei ka hana e ʻimi i ke kumu o ka maʻi hepatitis pohihihi, e pili ana i nā keiki a puni ka honua e ola mau ana. I kēia lā, ʻoi aku ma mua o 450 mau hihia i ʻike ʻia, ma kahi o 230 ma ʻEulopa wale nō. He mea pohihihi ka etiology o ka maʻi, akā, he mau manaʻo ko ka poʻe ʻepekema. Nui nā hōʻailona he hoʻopiʻi ka mumū o ke ake ma hope o COVID-19.

  1. No ka manawa mua, ua hāpai mua ka UK i nā hopohopo e pili ana i ka piʻi ʻana o ka maʻi hepatitis paʻakikī i nā keiki. I ka hoʻomaka ʻana o ʻApelila, ua hōʻike ʻia ma luna o 60 mau hihia o ka maʻi i aʻo ʻia. He nui kēia, e noʻonoʻo ana i ka ʻoiaʻiʻo i kēia manawa ma kahi o ʻehiku o lākou i ʻike ʻia i loko o ka makahiki
  2. I kekahi mau keiki, ua hoʻololi ka mumū i nā loli e pono ai ke hoʻololi i ke ake. Aia kekahi mau make mua ma muli o ka mumū
  3. Ma waena o nā kumumanaʻo i noʻonoʻo ʻia i nā loiloi o nā hihia maʻi, ʻo ke kumu viral ka mea nui. Ua manaʻo mua ʻia ʻo Adenovirus, akā i kēia manawa ua ʻike ʻia nā antibodies anti-SARS-CoV-2 i nā keiki hou aʻe.
  4. ʻO ka hapa nui o nā maʻi i ʻike ʻia i nā keiki liʻiliʻi ʻaʻole i hoʻopaʻa ʻia, no laila ua loaʻa paha iā lākou ka COVID-19 a ʻo ka mumū o ka ate he mea hoʻopiʻi ma hope o ka maʻi.
  5. Hiki ke loaʻa ka ʻike hou aku ma ka ʻaoʻao home Onet

ʻOi aku ka pilikia o ka ʻike ʻole i ke kumu ma mua o ka maʻi ponoʻī

ʻAʻole loaʻa ka maʻi hepatitis i loaʻa ʻole i nā keiki. No laila no ke aha i hoʻonui nui ai nā hihia hou o ka maʻi i ka honua? He maʻalahi ka pane: ʻaʻole i ʻike ʻia kekahi o nā ʻano maʻi maʻi maʻamau no ka maʻi hepatitis, ʻo ia hoʻi ʻo A, B, C a me D i ʻike ʻia i loko o ke koko o nā keiki maʻi. Eia kekahi, i ka hapanui o nā hihia, ʻaʻohe mea i ʻike ʻia i ka mumū. ʻO ka etiology i ʻike ʻole ʻia, ʻaʻole ka maʻi ponoʻī, ka mea weliweli. A hiki i kēia manawa, ʻo nā keiki olakino i maʻi koke, a paʻakikī loa no ke kumu ʻike ʻole, he mea hiki ʻole ke mālama ʻia.

ʻO ia ke kumu e nānā nei nā kauka, nā ʻepekema a me nā luna olakino a puni ka honua i nā hihia no nā hebedoma, e ʻimi ana i nā kumu kūpono. Ua noʻonoʻo ʻia nā koho like ʻole, akā ua kāpae koke ʻia ʻelua.

ʻO ka mea mua ka hopena o nā maʻi maʻi a me nā maʻi autoimmune e "makemake" e hoʻoulu a hoʻonui paha i ka mumū. Ua hōʻole koke ʻia kēia manaʻo, no ka mea ʻO ka hapa nui o nā keiki i ke olakino maikaʻi ma mua o ka loaʻa ʻana o ka maʻi hepatitis.

ʻO ka manaʻo ʻelua ka hopena o ka mea hana o ka lāʻau lapaʻau kūʻē iā COVID-19. Eia naʻe, ʻaʻole kūpono kēia wehewehe - ua pili ka maʻi i nā keiki ma lalo o 10 mau makahiki, a ʻo ka hui nui he mau makahiki (ma lalo o 5 mau makahiki). ʻO kēia nā keiki, i ka hapa nui o nā hihia, ʻaʻole i ʻae ʻia, no ka mea ʻaʻole lākou i kūpono no ka pale ʻana i ka COVID-19 (ma Polani, hiki ke hoʻopaʻa ʻia i nā keiki 5 mau makahiki, akā i nā ʻāina he nui a puni ka honua. , hiki wale i nā keiki 12 makahiki ke hoʻokokoke i ka injection).

Eia naʻe, ʻaʻole adenovirus?

Ma waena o nā manaʻo ʻoi aku ka hopena viral. Mai ka mea i hoʻokumu ʻia ʻaʻole kuleana ʻo HAV kaulana, HBC a i ʻole HVC no ka maʻi hepatitis i nā keiki, ua hoʻāʻo ʻia nā maʻi ʻōpio no ka loaʻa ʻana o nā pathogens ʻē aʻe. Ua ʻike ʻia he heluna nui o lākou i ʻike ʻia nā adenovirus (ʻano 41F). He microorganism kaulana ia no ka gastroenteritis, e kūlike me nā hōʻailona maʻamau o ka maʻi hepatitis i nā keiki (me ka ʻeha o ka ʻōpū, nausea, ka luaʻi ʻana, ka ʻōpū, ka piʻi ʻana o ka mahana).

ʻO ka pilikia, ʻo ka maʻi adenovirus ka mea e hoʻoulu ai i nā maʻi maʻalahi, a inā ʻoi aku ka pilikia o ke kaʻina o ka maʻi a hoʻopaʻa ʻia ke keiki i ka hale maʻi, ʻo ia ka mea maʻamau ma muli o ka dehydration ma mua o ka hoʻololi nui ʻana i nā ʻōpū o loko, e like me ke ʻano o ka maʻi hepatitis pohihihi. .

ʻO ke koena o ka kikokikona ma lalo o ke wikiō.

Ua loaʻa i nā keiki me ka maʻi hepatitis i ka maʻi coronavirus?

ʻO ka lua o ka hiki ke loaʻa ka maʻi me kahi ʻano maʻi ʻokoʻa. I ka wā o kahi maʻi maʻi, ʻaʻole hiki ke pale aku i ka hui ʻana me SARS-CoV-2, ʻoiai ʻo COVID-19 i nā keiki - e hoʻomaka ana mai ka maʻi maʻi, ma o ka papa a me ka mālama ʻana, a hiki i nā hoʻopiʻi - ʻaʻole i ʻike nui ʻia no ka lāʻau lapaʻau. Eia naʻe, ua loaʻa nā pilikia ma kēia ʻano.

ʻO ka mea hoʻokahi, ʻaʻole kēlā me kēia keiki me ka maʻi hepatitis ka moʻolelo o ka maʻi. ʻO kēia ma muli o ka ʻoiaʻiʻo nui nā maʻi pediatric, ʻoi aku ka nui o ka hoʻomaka ʻana o ka maʻi maʻi, i ka wā i mana nui ai nā ʻano like ʻole o Alpha a me Beta, ʻaʻohe hōʻailona - no laila, ʻaʻole ʻike paha nā mākua (a ʻoi aku hoʻi he pediatrician) a hiki i kēia lā ua loaʻa iā lākou ka COVID-19. Eia kekahi, ʻaʻole i hoʻokō ʻia ka hoʻāʻo ʻana ma kahi ʻano nui e like me nā nalu i hoʻokumu ʻia e nā ʻano ʻano Delta a me Omikron, no laila ʻaʻole nui nā "manawa" e ʻike ai i ka maʻi.

ʻO ka lua, ʻoiai inā he COVID-19 kāu keiki, ʻaʻole ʻike ʻia nā antibodies i loko o ko lākou koko (ʻoi aku inā ua hala ka manawa lōʻihi mai ka maʻi ʻana) No laila ʻaʻole hiki i nā poʻe maʻi ʻōpio āpau me ka maʻi hepatitis ke hoʻoholo inā ua loaʻa ka maʻi coronavirus. Aia kekahi mau hihia i loaʻa i kahi keiki i ka maʻi a ua loaʻa i ka COVID-19 kekahi hopena i ka hoʻomohala ʻana o ka mumū o ka ate, akā ʻaʻohe ala e hōʻoia ai i kēia.

He "superantigen" ia e hoʻonaʻauao ai i ka ʻōnaehana pale

ʻO ka noiʻi hou loa e pili ana i ka hopena o COVID-19 ma ke akepaʻa o nā keiki e hōʻike ana ʻaʻole ʻo SARS-CoV-2 wale nō ka mea hiki ke hoʻomake i ke kino. ʻO nā mea kākau o ka paʻi ʻana ma "The Lancet Gastroenterology & Hepatology" e hōʻike i kahi kaʻina kumu a me ka hopena. Ua loaʻa paha nā ʻāpana Coronavirus i ko lākou ala i loko o ka digestive tract i nā keiki a hoʻohuli i ka ʻōnaehana pale ma o ka hoʻoulu ʻana i ka adenovirus 41F. Ua pōʻino ka ate ma muli o ka hana ʻana o ka nui o nā protein inflammatory.

Ua hoʻomanaʻo ka "Journal of Pediatric Gastroenterology and Nutrition" i ka moʻolelo o kahi kaikamahine ʻekolu makahiki i loaʻa i ka maʻi hepatitis acute. I ka wā ninaninau me nā mākua ua hoʻokumu ʻia ua loaʻa ke keiki i ka COVID-19 i kekahi mau pule ma mua. Ma hope o nā hoʻokolohua kikoʻī (nā hoʻāʻo koko, biopsy ate), ua ʻike ʻia he ʻano autoimmune ka maʻi. Manaʻo paha kēia ua alakaʻi ʻo SARS-CoV-2 i kahi pane kūlohelohe kūlohelohe a hopena i ka hāʻule ʻole o ka ate.

"Ke manaʻo nei mākou e hoʻāʻo ʻia nā keiki me ka hepatitis acute no ka hoʻomau ʻana o SARS-CoV-2 i loko o ka waihona a me nā hōʻailona ʻē aʻe i hōʻino ʻia ke ake. ʻO ka protein spike coronavirus he "superantigen" e hoʻomāhuahua i ka ʻōnaehana pale»- wahi a nā mea kākau o ka haʻawina.

Makemake ʻoe e hana i nā hoʻokolohua pale no ka pilikia o ka maʻi ate? Hāʻawi ʻo Medonet Market i ka hoʻāʻo ʻana i ka leka uila o ka protein alpha1-antitrypsin.

Ua maʻi anei nā keiki i ka makahiki i hala?

Prof. Agnieszka Szuster-Ciesielska, virologist a me immunologist ma ke Kulanui ʻo Maria Curie-Skłodowska ma Lublin. Ua huki ka loea i ka nānā ʻana o nā kauka mai India, kahi i ka makahiki i hala (ma waena o ʻApelila a Iulai 2021) aia nā hihia i wehewehe ʻole ʻia o ka maʻi hepatitis koʻikoʻi i nā keiki. I kēlā manawa, ʻo nā lāʻau lapaʻau, ʻoiai hopohopo e pili ana i ke kūlana, ʻaʻole i hoʻokiʻekiʻe i ka alarm no ka mea ʻaʻohe mea i hōʻike i nā hihia like ma nā ʻāina ʻē aʻe. I kēia manawa ua hoʻopili lākou i kēia mau hihia a hōʻike i kā lākou ʻike.

Ma muli o ka nānā ʻana i nā keiki he 475 me ka maʻi hepatitis, ua ʻike ʻia ʻo ka mea maʻamau i kā lākou hihia ʻo ia ka maʻi me SARS-CoV-2 (e like me 47 i hoʻomohala i ka maʻi hepatitis koʻikoʻi). ʻAʻole i loaʻa i nā mea noiʻi India kahi hui me nā maʻi ʻē aʻe (ʻaʻole wale nā ​​​​mea nāna i hoʻokumu i ka maʻi hepatitis A, C, E, akā ua noiʻi ʻia pū kekahi varicella zoster, herpes a me cytomegalovirus), me ka adenovirus, aia wale nō i loko o kekahi mau laʻana.

– ʻO ka hoihoi, aia ka emi ʻana o ka nui o nā hihia o ka maʻi hepatitis i nā keiki i ka wā i hoʻōki ai ʻo SARS-CoV-2 i ka neʻe ʻana ma ka ʻāina a hoʻonui hou i ka wā i kiʻekiʻe ka nui o nā hihia. - hoʻoikaika i ka mea noiʻi.

Wahi a prof. ʻO Szuster-Ciesielska, i kēia manawa o ka noiʻi e pili ana i ka etiology o ka hepatitis i nā keiki, ʻo ka mea nui e makaʻala.

- He mea nui i nā kauka ke ʻike he kakaikahi ka maʻi hepatitis a hiki ke [hoʻomohala] i ka wā o kahi maʻi me SARS-CoV-2 a i ʻole ma hope o ka loaʻa ʻana o COVID-19. He mea nui ka hana ʻana i nā hoʻāʻo hana ate i nā maʻi i hoʻomaikaʻi ʻole e like me ka mea i manaʻo ʻia. ʻAʻole e hopohopo nā mākua, akā inā maʻi kā lākou keiki, pono paha e ʻike i kahi pediatric no ka nānā ʻana. ʻO ka hoʻomaʻamaʻa manawa kūpono ke kī i ka hoʻōla - ʻōlelo ka virologist.

He aha nā hōʻailona o ka hepatitis a me nā keiki?

ʻO nā hōʻailona o ka maʻi hepa i loko o kahi keiki he ʻano, akā hiki ke huikau me nā hōʻailona o ka gastroenteritis "maʻamau", ka "intestina" kaulana a i ʻole ka maʻi ʻōpū. ma mua:

  1. Nausea,
  2. abdominal eha,
  3. luaʻi,
  4. nā kūlohelohe,
  5. ka nele o kaʻai
  6. fiva,
  7. ʻeha i nā mākala a me nā hono,
  8. nawaliwali, luhi,
  9. ʻeleʻele melemele o ka ʻili a me / a i ʻole nā ​​maka maka,

ʻO kahi hōʻailona o ka ʻaʻa o ke akepaʻa, ʻo ia ka wehe pinepine ʻana o ka mimi (ʻeleʻele ia ma mua o ka mea maʻamau) a me ka ʻili (he ʻeleʻele, hina).

Inā ulu kāu keiki i kēia ʻano maʻi, pono ʻoe e nīnau koke i ka pediatrician a i ʻole ke kauka lapaʻaua inā hiki ʻole kēia, e hele i ka haukapila, kahi e hoʻokolokolo pono ai ka mea maʻi liʻiliʻi.

Paipai mākou iā ʻoe e hoʻolohe i ka hanana hou loa o ka RESET podcast. I kēia manawa, hoʻolaʻa mākou i ka meaʻai. Pono ʻoe e hoʻopili iā ia 100% e noho olakino a maikaʻi? Pono ʻoe e hoʻomaka i kēlā me kēia lā me ka ʻaina kakahiaka? Pehea ka ʻai ʻana i ka ʻai a me ka ʻai ʻana i nā hua? E hoʻolohe:

Waiho i ka Reply